Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined onabotulinumtoxinA and hyaluronic acid filler for enlarged facial pores
TCTR20250115002Phase 3Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A, hyaluronic acid, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Aug 2023; status: completed.
02
Drugs
botulinum toxin type Ahyaluronic acid
Beyond the preview
Go deeper on TCTR20250115002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250115002.